Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data sources
1.5.1 Primary
1.5.2 Secondary
1.5.2.1 Paid sources
1.5.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of sports related injuries
3.2.1.2 Rising incidence of bone related disorders
3.2.1.3 Growing technological advancements
3.2.1.4 Increasing awareness regarding physical fitness
3.2.2 Industry pitfalls & challenges
3.2.2.1 Inflated of cost of tendonitis treatment
3.2.2.2 Lack of reimbursement scenario
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
Chapter 5 Market Estimates and Forecast, By Treatment, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Therapy
5.2.1 Hot & cold therapy
5.2.2 Physical therapy
5.2.3 Shockwave therapy
5.3 Surgery
5.4 Medications
5.4.1 Oral
5.4.2 Topical
Chapter 6 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Achilles tendonitis
6.3 Supraspinatus tendonitis
6.4 Tennis elbow
6.5 Pitcher's elbow
6.6 Jumper's knee
Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospital pharmacy
7.3 Retail pharmacy
7.4 Online pharmacy
Chapter 8 Market Estimates and Forecast, By End-Use, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Specialty clinics
8.4 Home care settings
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.2 AstraZeneca
10.3 Boehringer Ingelheim Pharmaceuticals, Inc.
10.4 Bristol Myers Squibb Company
10.5 Colfax Corporation
10.6 GalxoSmithKline AG
10.7 Johnson & Johnson
10.8 Merck and Co., Inc.
10.9 Ossur
10.10 Pifzer Inc.
10.11 Stryker Corporation
10.12 Teva Pharmaceutical Industries Ltd.
10.13 Tynor Orthotics Pvt. Ltd
10.14 Zimmer Biomet Holdings, Inc.
